Pipeline
Therapeutic Pipeline
Select programs from Valo's pipeline
| Program Description | Target Discovery | Molecule Discovery | Ind Enabling | Phase 1 | Phase 2 |
|---|---|---|---|---|---|
| Diabetic Retinopathy; Diabetic Macular Edema*; Diabetic Complications* |
OPL-04011 |
||||
| Acute Kidney Injury; Heart Failure* |
OPL-03012 |
||||
| Atherosclerosis |
OPAL-0022 |
||||
| Heart Failure |
OPL-0016 |
||||
| Heart Failure/Metabolic Syndrome |
OPAL-0018 |
||||
| Immuno-Oncology |
OPL-01013 |
||||
| Immuno-Oncology |
OPAL-0001 |
Future programs with target hypothesis identified
Oncology
(2 early discovery)
0021
0012
Neurodegeneration
(1 early discovery)
0016
Contact us to learn more
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.